DE3212909C2 - - Google Patents

Info

Publication number
DE3212909C2
DE3212909C2 DE3212909A DE3212909A DE3212909C2 DE 3212909 C2 DE3212909 C2 DE 3212909C2 DE 3212909 A DE3212909 A DE 3212909A DE 3212909 A DE3212909 A DE 3212909A DE 3212909 C2 DE3212909 C2 DE 3212909C2
Authority
DE
Germany
Prior art keywords
effect
theophylline
diethylaminoethyl
acetylsalicylic acid
solvent
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE3212909A
Other languages
German (de)
English (en)
Other versions
DE3212909A1 (de
Inventor
Concepcion Barcelona Es Coma Julia
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of DE3212909A1 publication Critical patent/DE3212909A1/de
Application granted granted Critical
Publication of DE3212909C2 publication Critical patent/DE3212909C2/de
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
    • C07D473/04—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms
    • C07D473/06—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3
    • C07D473/08—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3 with methyl radicals in positions 1 and 3, e.g. theophylline

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DE19823212909 1981-04-07 1982-04-06 7-(2-diaethylaminoaethyl)-theophyllin-acetylsalicylat und verfahren zu seiner herstellung Granted DE3212909A1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ES501162A ES501162A0 (es) 1981-04-07 1981-04-07 Procedimiento para la obtencion de acetilsalicilato de 7-(2-dietilaminoetil)-teofilina

Publications (2)

Publication Number Publication Date
DE3212909A1 DE3212909A1 (de) 1982-11-18
DE3212909C2 true DE3212909C2 (ko) 1990-07-26

Family

ID=8482205

Family Applications (1)

Application Number Title Priority Date Filing Date
DE19823212909 Granted DE3212909A1 (de) 1981-04-07 1982-04-06 7-(2-diaethylaminoaethyl)-theophyllin-acetylsalicylat und verfahren zu seiner herstellung

Country Status (6)

Country Link
CH (1) CH647780A5 (ko)
DE (1) DE3212909A1 (ko)
ES (1) ES501162A0 (ko)
GB (1) GB2096138B (ko)
IT (1) IT1153967B (ko)
PT (1) PT74716B (ko)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3508097A1 (de) * 1984-07-21 1986-02-06 Hoechst Ag, 6230 Frankfurt Kombinationspraeparat aus xanthinderivaten und o-acetylsalicylsaeure bzw. deren pharmakologisch vertraeglichen salzen und dessen verwendung
ES2009604A6 (es) * 1988-05-05 1989-10-01 Coma Julia Concepcion Procedimiento de obtencion de acetil-salicilato de 7-(2-dietilaminoetil)-teofilina.

Also Published As

Publication number Publication date
IT1153967B (it) 1987-01-21
ES8202009A1 (es) 1982-02-01
PT74716A (en) 1982-05-01
ES501162A0 (es) 1982-02-01
CH647780A5 (de) 1985-02-15
IT8220487A0 (it) 1982-03-30
GB2096138A (en) 1982-10-13
PT74716B (en) 1983-11-14
GB2096138B (en) 1984-08-01
DE3212909A1 (de) 1982-11-18

Similar Documents

Publication Publication Date Title
DE69003575T2 (de) Formulierung, ein Imidazo[4,5-c]Quinolin-Derivat enthaltend.
DE69113386T2 (de) Herstellung von Medikamenten zur Behandlung von Asthma, unter Verwendung von (S)-Alpha-Fluoromethyl-Histidin und dessen Estern.
EP0138018B1 (de) Lösungen milchsaurer Salze von Piperazinylchinolon- und Piperazinyl-azachinoloncarbonsäuren
DE1768806C3 (de) Komplexe bzw. Salze aus einer antikoagulierend bzw. antilipämisch wirkenden sauren Heparinoidsäure-Komponente und einer nicht-toxischen Aminosäure bzw. organischen Base
EP0214620B1 (de) Transdermale Applikationsform von Diltiazem
DE19743968A1 (de) Intravenöse Applikationsform von Thalidomid zur Therapie immunologischer Erkrankungen
DE2716402A1 (de) 7-(2,3-dihydroxypropyl)-1,3-di-n- propylxanthin, verfahren zu seiner herstellung und diese verbindung enthaltende arzneimittel
DE69306990T2 (de) Physostigmin-Derivate, ihre Verwendung und sie enthaltende pharmazeutische Formulierungen
DE2166355C2 (de) Verwendung von d,1-Sobrerol bei der Balsamtherapie der Atemwege
DE3212909C2 (ko)
EP0817623B1 (de) Arzneistoffe zur selektiven bekämpfung von tumorgewebe
DE3141970C2 (ko)
EP0207193A2 (de) Synergistische Kombination von Flupirtin und 4-Acetamido-phenol
DE3425466A1 (de) Synergistisches arzneimittelpraeparat zur behandlung von leberkrankheiten
DE3419425C2 (ko)
DE3689254T2 (de) Arzneimittel auf Dextrorphanbasis zur intranasalen Applikation.
DE2318784A1 (de) N-(2,4-dihydroxybenzoyl)-4-aminosalizylsaeure
DE2916880C2 (de) Arzneimittel mit sedativer und schlafinduzierender Wirkung
DE2518509C3 (de) Pharmazeutisches Mittel für Antitumoraktivität, enthaltend Abrin
DE2521905C2 (de) Arzneimittel zur cerebralen Durchblutungsförderung
DE2635293A1 (de) Salzgemisch, insbesondere leicht assimilierbares arzneimittelgemisch mit erhoehter loeslichkeit, enthaltend kalziumsalze und/oder magnesiumsalze
DE2755017A1 (de) Oral verabreichbare arzneimittel mit psychostimulierender wirkung
EP0352652B1 (de) Verwendung von Imexon als Immunsuppressivum
DE2461570B2 (de) Arzneimittel für die Behandlung bakterieller Infektionen der Augen und/oder der Ohren und Verfahren zu ihrer Herstellung
DE2221281B2 (de) Pharmazeutische Zubereitungen mit entzündungshemmender und analgetischer Wirkung

Legal Events

Date Code Title Description
8110 Request for examination paragraph 44
D2 Grant after examination
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee